NanoenTek Inc. | Income Statement

Fiscal year is January-December. All values KRW Millions.
2013
2014
2015
2016
2017
Sales/Revenue
19,084
19,499
24,839
22,206
23,810
Cost of Goods Sold (COGS) incl. D&A
14,732
15,290
20,025
18,965
15,022
Gross Income
4,352
4,209
4,814
3,240
8,788
SG&A Expense
4,729
6,629
11,809
12,760
6,957
EBIT
473
2,592
7,211
9,685
1,672
Unusual Expense
-
-
795
4,984
1,038
Non Operating Income/Expense
95
214
653
80
1,263
Interest Expense
1,069
309
221
230
495
Pretax Income
1,237
2,464
7,471
14,799
2,072
Consolidated Net Income
1,237
2,464
7,471
14,799
2,072
Net Income
1,237
2,464
7,282
14,799
2,072
Net Income After Extraordinaries
1,237
2,464
7,282
14,799
2,072
Net Income Available to Common
1,237
2,464
7,282
14,799
2,072
EPS (Basic)
63.00
113.00
314.00
607.00
85.00
Basic Shares Outstanding
20
22
23
24
24
EPS (Diluted)
63.02
112.70
314.17
606.58
84.78
Diluted Shares Outstanding
20
22
23
24
24
EBITDA
1,288
406
4,455
6,850
4,516
Other Operating Expense
96
171
216
166
158
Non-Operating Interest Income
401
222
102
20
79
Minority Interest Expense
-
-
189
-
-
Equity in Affiliates (Pretax)
-
-
-
-
1,028

About NanoenTek

View Profile
Address
12th Floor, Ace High-End Tower 1 Cha
Seoul SL 08389
Korea, Republic Of
Employees -
Website http://www.nanoentek.com
Updated 09/14/2018
NanoenTek, Inc. engages in the manufacture and sale of diagnostics and analytical equipment. Its products include live cell movie and diagnostic test analyzers, cell counting, sample banking, immunoassay, and counting starter, friend, and rapid kits. The company was founded on November 18, 1987 and is headquartered in Seoul, South Korea.